Wilmington, Massachusetts -- AdvanSource Biomaterials Corp., a developer of polymer materials for the medical industry, has announced its product lines are compliant with European Council safety measures to prevent contamination during the manufacturing process. "We are proud of the initiatives we take to respond to the concerns of our growing number of medical device customers in a proactive and timely manner," the company said 8 Feb.
The EC measures apply to "the process of certain animal waste to protect against transmissable spongiform encephalopathies as set forth in the European Council Decision 1999/534/EC."
"We recognise that the risk of infectious agent contamination, such as TSE (transmissable spongiform encephalopathies) and BSE (bovine spongiform encephalopathy), is mitigated through controlled sourcing and qualified evaluation of all of our starting steps," said Khristine Carroll, AdvanSource's senior vice president of commercial operations. "Accordingly, we have undertaken a complete review of our materials, processes and raw material suppliers to proactively respond to the device industries growing concern regarding this issue," she added. (RD)